|
POLR1E expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.544070E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.079600E-03 |
| Normal-vs-Stage2 |
2.719400E-03 |
| Normal-vs-Stage3 |
7.303900E-03 |
| Normal-vs-Stage4 |
6.812100E-02 |
| Stage1-vs-Stage2 |
2.011000E-01 |
| Stage1-vs-Stage3 |
8.547000E-01 |
| Stage1-vs-Stage4 |
6.577000E-01 |
| Stage2-vs-Stage3 |
2.456200E-01 |
| Stage2-vs-Stage4 |
1.536030E-01 |
| Stage3-vs-Stage4 |
5.521200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.777100E-03 |
| Normal-vs-AfricanAmerican |
4.589600E-01 |
| Normal-vs-Asian |
9.530400E-02 |
| Caucasian-vs-AfricanAmerican |
4.138000E-01 |
| Caucasian-vs-Asian |
6.251600E-01 |
| AfricanAmerican-vs-Asian |
6.813400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.679500E-03 |
| Normal-vs-Female |
2.463800E-03 |
| Male-vs-Female |
7.911600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.663300E-03 |
| Normal-vs-Age(41-60Yrs) |
7.060600E-03 |
| Normal-vs-Age(61-80Yrs) |
7.796800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.358210E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.433600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.969200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.046600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.390200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.781400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.537600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.735400E-01 |
| Classical-VS-Follicular |
3.385900E-04 |
| Classical-VS-Other |
7.198400E-01 |
| Classical-VS-Normal |
6.267900E-02 |
| Tall-VS-Follicular |
3.064000E-02 |
| Tall-VS-Other |
8.545200E-01 |
| Tall-VS-Normal |
4.724200E-02 |
| Follicular-VS-Other |
5.136400E-01 |
| Follicular-VS-Normal |
1.61576999999635E-05 |
| Other-VS-Normal |
4.306000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.246400E-04 |
| Normal-vs-N1 |
7.205000E-04 |
| N0-vs-N1 |
4.272000E-01 |
|
|
